- Home
- CTNT vs ARTL Comparison
CTNT vs ARTL Comparison
Compare CTNT & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- ARTL
- Stock Information
- Founded
- CTNT 2016
- ARTL 2011
- Country
- CTNT United States
- ARTL United States
- Employees
- CTNT N/A
- ARTL N/A
- Industry
- CTNT
- ARTL Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- ARTL Health Care
- Exchange
- CTNT Nasdaq
- ARTL Nasdaq
- Market Cap
- CTNT 6.1M
- ARTL 6.7M
- IPO Year
- CTNT 2023
- ARTL N/A
- Fundamental
- Price
- CTNT $1.77
- ARTL $3.43
- Analyst Decision
- CTNT
- ARTL Buy
- Analyst Count
- CTNT 0
- ARTL 2
- Target Price
- CTNT N/A
- ARTL $30.00
- AVG Volume (30 Days)
- CTNT 20.1K
- ARTL 74.1K
- Earning Date
- CTNT 11-12-2025
- ARTL 11-11-2025
- Dividend Yield
- CTNT N/A
- ARTL N/A
- EPS Growth
- CTNT N/A
- ARTL N/A
- EPS
- CTNT N/A
- ARTL N/A
- Revenue
- CTNT $1,119,333.00
- ARTL N/A
- Revenue This Year
- CTNT $302.80
- ARTL N/A
- Revenue Next Year
- CTNT $22.22
- ARTL N/A
- P/E Ratio
- CTNT N/A
- ARTL N/A
- Revenue Growth
- CTNT N/A
- ARTL N/A
- 52 Week Low
- CTNT $1.12
- ARTL $3.15
- 52 Week High
- CTNT $8.50
- ARTL $28.60
- Technical
- Relative Strength Index (RSI)
- CTNT 49.04
- ARTL 28.90
- Support Level
- CTNT $1.66
- ARTL $3.15
- Resistance Level
- CTNT $1.80
- ARTL $4.34
- Average True Range (ATR)
- CTNT 0.09
- ARTL 0.39
- MACD
- CTNT -0.01
- ARTL 0.01
- Stochastic Oscillator
- CTNT 43.85
- ARTL 15.38
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.